| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201362 | Ophthalmology | 2015 | 8 Pages |
Abstract
For children 7 to 12 years of age with residual amblyopia after patching therapy, oral levodopa while continuing to patch 2 hours daily does not produce a clinically or statistically meaningful improvement in VA compared with placebo and patching.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Pediatric Eye Disease Investigator Group Pediatric Eye Disease Investigator Group, Michael X. (Writing Committee), Raymond T. (Writing Committee), Trevano W. (Writing Committee), Roy W. (Writing Committee), R. Michael (Writing Committee),